You are here

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Espoo Vaccine Research Clinic
Espoo, , 02230 Finland
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Meningococcal Infections
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

All subjects must satisfy ALL the following criteria at study entry:

- Subjects' parent(s)/Legally Acceptable Representative(s) [LAR(s)] who, in the opinion
of the investigator, can and will comply with the requirements of the protocol.

- A male or female who has received primary and booster vaccination with the MenACWY-TT
or Meningitec vaccines in studies MENACWY-TT-039 (109670) and MENACWY-TT-048 EXT: 039
Y2, 3, 4, 5 (112036), respectively.

- Written informed consent obtained from the parent(s)/LAR(s) of the subject.

- Healthy subjects as established by medical history and clinical examination before
entering into the study.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

The following criteria should be checked at the time of study entry. If ANY exclusion
criterion applies, the subject must not be included in the study:

- Child in care.

- History of meningococcal disease.

- Administration of a meningococcal polysaccharide or a meningococcal polysaccharide
conjugate vaccine outside of studies MENACWY-TT-039 (109670) and MENACWY-TT-048 EXT:
039 Y2, 3, 4, 5 (112036).

- Any confirmed or suspected immunosuppressive or immunodeficient condition, based on
medical history and physical examination.

- Bleeding disorders, such as thrombocytopenia, or subjects on anti-coagulant therapy.

NCT01900899
Pfizer
Completed
Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now